November 27, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Arkray Introduces Two Diabetes Testing Devices
 

 HA-8170
Tokyo, Mar 10, 2006 (JCN) - Arkray began marketing the SPOTOCHEM IM SI-3511 and ADAMS A1c HA-8170, two new analyzers for use in diabetes diagnosis, on March 9.

The SI-3511, which measures 330x224x185mm and weighs about 6kg, can measure whole blood, serum and plasma. It takes 10-13 minutes to complete a test. Available at 1,700,000 yen (US $14,400), the product is suitable for use by clinics and private practitioners.

The HA-8170, which adopts a high-performance liquid chromatography (HPLC) method, is designed for the measurement of HbA1c. It takes only 90 seconds to conduct a test and can automatically analyze up to 100 samples. The 40kg device measures 530x530x530mm and retails for 6,700,000 yen ($56,770).


By Aki Tsukioka Contributor

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  ARKRAY,Inc. News  
  ARKRAY to Release 'Naturalet' Puncture Device and Needle for Blood Collection  (June 29, 2006)
  ARKRAY to Release 'Naturalet' Puncture Device and Needle for Blood Collection  (June 29, 2006)
  Arkray Introduces Two Diabetes Testing Devices  (Mar 10, 2006)
  ARKRAY Introduces World's Smallest and Lightest Urine Analyzer PocketChem UA PU-4010  (July 29, 2005)
  ARKRAY Now Distributes MC Laboratory's Blood Fluidity Analyzer MC FAN HR300  (June 13, 2005)
  ARKRAY to Introduce New Urine Test Strip for Use by Medical Institutions  (Dec 7, 2004)
  Arkray, MC Laboratory to Form Strategic Alliance in Blood Fluidity Analyzer Business  (July 15, 2004)
  Arkray to Introduce Automated Portable Blood Gas Analyzer  (Apr 2, 2004)



 Recent  Medical News   
Otsuka Group Establishes New Company; Strengthens Presence in Vending Machine Market (Nov 17, 2014)
Otsuka's 'QuickNavi-Flu' Diagnostic Kit to Provide Additional Diagnosis-Related Information (Oct 14, 2014)
Nitto Denko Anti-fibrosis Drug Starts Phase-1b Dosing for Cirrhosis Patients in the US (Oct 10, 2014)
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)

More Medical news...

 Recent  Medical News   
Otsuka Group Establishes New Company; Strengthens Presence in Vending Machine Market (Nov 17, 2014)
Otsuka's 'QuickNavi-Flu' Diagnostic Kit to Provide Additional Diagnosis-Related Information (Oct 14, 2014)
Nitto Denko Anti-fibrosis Drug Starts Phase-1b Dosing for Cirrhosis Patients in the US (Oct 10, 2014)
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)

More Medical news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)